Skip to main content

Table 1 Blood test result on admission of case 1

From: Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature

Laboratory findings

 

Reference value

WBC (×103/μL)WBC (×103/μL)

6.9

3.3 - 8.6

Seg (%)

70.8

38 - 74

Lymph (%)

13.7

16.5 - 49.5

Mono (%)

13.7

2 - 10

Eosino (%)

0.4

0 - 8.5

RBC (×106μL)RBC (×106μL)

3.27

4.35 - 5.55

Hg (g/dL)

10.6

13.7 - 16.8

Hct (%)

32.1

40.7 - 50.1

Plt (μL)

135

158 - 348

TP (g/dL)

5.6

6.6 - 8.1

Alb (g/dL)

2.8

4.1 - 5.1

AST (IU/L)

16

13 - 30

ALT (IU/L)

10

10 - 42

LDH (IU/L)

256

124 - 222

BUN (mg/dL)

11

8 - 20

Cr (mg/dL)

0.91

0.65 - 1.07

CRP (mg/dL)

4.8

0.00 - 0.14

KL-6 (U/mL)

754

105.3 - 401.2

Anti-nuclear antibodies (n times)

< 80

< 80

Anti-ARS antibody (INDEX)

< 5.0

< 25

Anti-CCP antibody (U/mL)

< 0.6

< 4.5

Anti-SS-A antibody (U/mL)

3.4

< 10

Anti-SS-B antibody (U/mL)

< 1.0

< 10

MPO-ANCA (U/mL)

< 1.0

< 3.5

PR3-ANCA (U/mL)

< 1.0

< 3.5

Beta D-Glucan (pg/mL)

20.5

< 20

Cytomegalovirus antigen C7HRP

negative